X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

ACG Films and Foils and Danapak Flexibles A/S enters Strategic Partnership for India

Content Team by Content Team
5th August 2021
in Packaging & Logistic, Press Statements
ACG Films and Foils and Danapak Flexibles A/S enters Strategic Partnership for India

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

ACG, one of world’s most integrated pharmaceutical supplier, announced its strategic partnership with Danapak Flexibles A/S, the global market leader in packaging for high barrier Transdermal Drug Delivery systems. The partnership will translate into better services to existing and new customers of Danapak Flexibles in India.

ACG Films & Foils and Danapak Flexibles’s collective product offerings will now include a broad range of high barrier quality laminates and flexible packaging laminates, including a broad spectrum of suitable alternatives to Barex specifications used for Rivastigmine, Nicotine, Rotigotine, Lidocaine, Fentanyl, Buprenorphine and other API’s.

Confident of the synergies that will stem from the strategic partnership, Mr. L.W Hyldgaard, Managing Director, Danapak Flexibles said, “We are proud to be associated with ACG Films & Foils as our partners in India. Over the years, with innovative solutions and superior customer services, ACG has positioned itself as a formidable player in the global pharmaceutical industry. We are certain this partnership will go a long way and bring better services and more innovative solutions for our customers in India.”

Resonating with Mr. Hyldgaard, Mr. S.R Shivshankar, CEO, ACG Films & Foils, said, “We are excited to be chosen for the strategic partnership with Danapak- a brand that is recognized for the best products in its class, globally. With our collective technical expertise and ACG’s understanding of the local market, we are confident that together, we will be able to serve the customers with innovative and a wide range of solutions for their high barrier quality laminates requirements.”

About ACG:
In accordance with its commitment to making the world healthier, ACG has now been delivering exceptional solutions to the global pharmaceutical and nutraceutical industry for almost sixty years, across six continents and in a hundred countries. ‘Collaboration’ is at the core of ACG’s ethos, and ACG is the world’s only integrated pharma manufacturing solutions company, with products ranging from Capsules to Films & Foils, to Engineering equipment, and Inspection systems – all that meet international regulatory requirements. For ACG, it’s always about finding innovative solutions to the world’s greatest health challenges, together.

 

ACG Films and Foils and Danapak Flexibles A/S enters Strategic Partnership for India

Previous Post

UAE approves use of Sinopharm vaccine for children aged between 3 and 17 years

Next Post

Envirotainer Welcomes China Southern Airlines as the first mainland China carrier to approve the Releye RLP

Related Posts

Packaging & Logistic

VarioFill: Rotzinger sets new standards with highly flexible filling and capping platform for OTC products

30th August 2025
Major Depressive Disorder
Americas

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

27th August 2025
Schott-Testing
Press Statements

Carbon Reduced Pharmaceutical Glass: SCHOTT Melting Tank Construction Starts and External Certification for FIOLAX® Pro OCF

11th August 2025
Future Trends Shaping
Packaging & Logistic

Future Trends Shaping Pharma Supply Chain and Logistics

30th July 2025
GSK and Hengrui Pharma
Drug Development

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

29th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Next Post
Envirotainer Welcomes China Southern Airlines as the first mainland China carrier to approve the Releye RLP

Envirotainer Welcomes China Southern Airlines as the first mainland China carrier to approve the Releye RLP

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In